Hypotheses on a germline origin of antibody diversity. Possible applications: Improvement of the efficiency of immune response and autoimmune disease treatment

Medical Hypotheses

Volumn 63, Issue 5, 2004, Pages 847-854

  Berger, G ^a  

^a 14 Impasse des Carpeaux ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIPEPTIDE; EPITOPE; IMMUNOGLOBULIN;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; HUMAN; IMMUNE RESPONSE; MICROORGANISM; PRIORITY JOURNAL; SOMATIC MUTATION; THYMUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY DIVERSITY; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNE DISEASES; EPITOPES; HUMANS; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MODELS, GENETIC; MODELS, IMMUNOLOGICAL;

EID: 5644261320     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.055     Document Type: Article

References (30)

1. Tonegawa S. Somatic generation of antibody diversity. Nature. 302:1983;575-581
2. Andria M., Levy S., Benjamini E. Diverse VH and VL genes are used to produce antibodies against a defined protein epitope. J. Immunol. 144:1990;2614-2619
3. Liu J., Minnerath J., Nelson R., Mueller C., Jemmerson R. Kinetic and genetic bases for the heteroclitic recognition of mouse cytochrome c by mouse anti-pigeon cytochrome c monoclonal antibodies. J. Immunol. 37:2000;847-859
4. Chen C., Roberts V., Stevens S., Brown M., Stenzel-Poore M., Rittenberg M. Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J. 14:1995;2784-2794
5. Sela M. Antigenicity: some molecular aspects. Science. 166:1969;1365-1374
6. Schechter I. Mapping of the combining sites of antibodies specific for poly L alanine determinants. Nature. 228:1970;639-641
7. Schechter B., Schechter I., Ramachandran J., Conway-Jacobs A., Sela M., Benjamini E., et al. Eur. J. Biochem. 20:1970;309-320
8. Geysen H. Antigen-antibody interactions at the molecular level: adventures in peptide synthesis. Immunol. Today. 6:1985;364-369
9. Lambin P. Immunoglobulin genes and the origin of antibody diversity. Rev. Fr. Transfus. Hemobiol. 35:1992;47-65
10. Talmage D. Immunological specificity. Science. 129:1959;1643-1648
11. Zmijewski C., Bellanti J. Bellanti Immunology basic processes. 2nd ed.:1985;160-175 W. Saunders Cie
12. Hosoi S., Shinomiya K., Mikawa H. The use of monoclonal antibodies in demonstrating the effect of antibody heterogeneity on immune complex size. Clin. Immunol. Immunopathol. 32:1984;378-386
13. Berger G. Deterministic hypotheses on the origin of life and of its reproduction. Med. Hypotheses. 61:2003;586-592
14. Saroff H. The uniqueness of protein sequences: molecular territoriality. J. Theor. Biol. 115:1985;191-199
15. Crumpton M. In: MTP international review of science biochemistry. Series 1. Defence and recognition, vol. 10. Butterworths University Park Press. p. 133-58
16. Mc Michael A., Phillips R. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:1997;271-296
17. Wodarz D., Nowak M. Dynamics of immune escape in HIV infection. Wien. Klin. Wochenschr. 111:1999;419-427
18. Klenerman P., Phillips R. HIV: current opinion in escapology. Curr. Opin. Microbiol. 5:2002;408-413
19. Borst P., Rudenko G., Blundell P., van Leeuwen F., Cross M., Mc Culloch R., et al. Mechanisms of antigenic variation in African trypanosomes. Behring Inst. Mitt. 99:1997;1-15
20. Powell P. Can site-directed mutagenesis eliminate autoimmunity arising from molecular mimicry? Med. Hypotheses. 50:1998;399-407
21. Berger G. Proposition of treatment to improve the immune response: possible application to AIDS. Med. Hypotheses. 58:2002;416-421
22. Roitt I., Hutchings P., Dawe K., Sumar N., Bodman K., Cooke A. The forces driving autoimmune disease. J. Autoimmun. 5(Suppl.5A):1992;11-26
23. Gerling I., Serreze D., Christianson S., Leiter E. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes. 41:1992;1672-1676
24. Nomura Y., Stein E., Mullen Y. Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobese diabetic (NOD) mice. Transplantation. 56:1993;638-642
25. Charlton B., Taylor-Edwards C., Tisch R., Fathman C. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmun. 7:1994;549-560
26. Duncan S., Rubin R., Burlingame R., Sinclair S., Pekny K., Theofilopoulos A. Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice. Clin. Immunol. Immunopathol. 79:1996;171-181
27. Khoury S., Sayegh M., Hancock W., Gallon L., Carpenter C., Weiner H. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J. Exp. Med. 178:1993;559-566
28. Goss J., Nakafusa Y., Roland C., Hickey W., Flye M. Immunological tolerance to a defined myelin basic protein antigen administrated intrathymically. J. Immunol. 153:1994;3890-3898
29. Koevary S., Caspi R. Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection. Ocul. Immunol. Inflamm. 5:1997;165-172
30. Elias D., Tikochinski Y., Frankel G., Cohen I. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int. Immunol. 11:1999;957-966